Related Experiment Video
Updated: Jan 28, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment
George Makavos1, Chris Κairis1, Maria-Eirini Tselegkidi2
12nd Cardiology Department, National and Kapodistrian University of Athens, Attikon Hospital, Rimini 1, 12462, Haidari, Greece.
Insights
Hypertrophic cardiomyopathy (HCM) is a heart condition with many causes. This review covers its diagnosis, genetics, prognosis, and treatment, focusing on sudden cardiac death risk.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- Hypertrophic cardiomyopathy (HCM) is defined as left ventricular hypertrophy without abnormal loading conditions.
- Numerous underlying etiologic factors contribute to the HCM phenotype.
- The MOGE(S) classification offers a standardized multimodal characterization of HCM.
Purpose of the Study:
- To provide a comprehensive review of current knowledge on hypertrophic cardiomyopathy.
- To summarize recent data on clinical presentation, diagnosis, and management of HCM.
- To emphasize the importance of risk stratification for sudden cardiac death in HCM patients.
Main Methods:
- Literature review of essential knowledge and recent publications on HCM.
- Synthesis of information on clinical aspects, genetic analyses, and differential diagnosis.
- Analysis of prognostic factors and current treatment strategies for HCM.
Main Results:
- HCM has diverse etiologies, requiring multimodal assessment using classifications like MOGE(S).
- Accurate diagnosis, including genetic analysis and differential diagnosis, is crucial.
- Risk stratification for sudden cardiac death is a paramount concern in HCM management.
Conclusions:
- Understanding the multifaceted nature of HCM is essential for effective patient management.
- A standardized approach to characterization and risk assessment improves clinical decision-making.
- Comprehensive knowledge of diagnosis, prognosis, and treatment options is vital for improving outcomes in HCM.
Abstract:
Hypertrophic cardiomyopathy (HCM) represents a phenotype of left ventricular hypertrophy unexplained by abnormal loading conditions. The definition is based on clinical criteria; however, there are numerous underlying etiologic factors. The MOGE(S) classification provides a standardized approach for multimodal characterization of HCM. HCM is associated with increased morbidity and mortality, and especially the assessment of the risk of sudden cardiac death is of paramount importance. In this review, we summarize essential knowledge and recently published data on clinical presentation, diagnosis, genetic analyses, differential diagnosis, prognosis, and treatment options that are necessary for understanding and management of HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

